Long, H J <br/><br/>
A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic.  [electronic resource] 

 -  Cancer  Aug 1991 
 - 730-2 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19910815)68:4<730::aid-cncr2820680411>3.0.co;2-c  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma--drug therapy<br/>Cisplatin--therapeutic use<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Menogaril<br/>Middle Aged<br/>Nogalamycin--adverse effects<br/>Ovarian Neoplasms--drug therapy<br/>Recurrence<br/>Remission Induction<br/>Survival Analysis